#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Ovarian cancer Dementia Alzheimer's type Colorectal cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Malignant melanoma Non-small cell lung cancer metastatic Asthma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Fatty acid oxidation disorder Cortical dysplasia Hypereosinophilic syndrome Mucopolysaccharidosis I Langerhans cell sarcoma Ischaemic stroke Meningococcal immunisation C3 glomerulopathy Multifocal motor neuropathy Marfan's syndrome Adenovirus infection Breast cancer Anti-neutrophil cytoplasmic antibody positive vasculitis Fibrosarcoma Adrenogenital syndrome More trials…

    Learn about Rare Diseases

    Wiskott-Aldrich syndrome – Life with Disease Kearns-Sayre syndrome – Treatment Adrenogenital syndrome – Treatment Mucous membrane pemphigoid – Life with Disease Haemolytic uraemic syndrome – Diagnostics Lymphangiosarcoma – Diagnostics Mucopolysaccharidosis I Undifferentiated sarcoma – Life with Disease Breast angiosarcoma metastatic – Life with Disease Rosai-Dorfman syndrome – Trials in Disease More diseases…
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Padeliporfin Imiquimod Clavulanic Acid Damoctocog Alfa Pegol Methylprednisolone Florbetapir (18F) Human Albumin Solution Satralizumab 64CU-PSMA I&T Anidulafungin Sym024 Doxycycline Hyclate Alks 2680 TUVATEXIB Clomifene Citrate Verapamil Hydrochloride Oregovomab Hydroxocobalamin Pelareorep Sodium Nitroprusside Dihydrate More therapies…

    Learn about Your Condition

    Myxofibrosarcoma Petit mal epilepsy Food allergy Congenital aplastic anaemia Arthroscopy Blood disorder High-grade B-cell lymphoma Adenocarcinoma of colon Retroperitoneal fibrosis Cachexia Anal cancer Extraskeletal ossification Pulmonary sarcoidosis Obsessive-compulsive disorder Thyroid cancer metastatic More diseases…
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Cluj Napoca

  • Study of eftilagimod alpha with pembrolizumab combination therapy for patients with metastatic head and neck cancer who have not received previous treatment

    Not recruiting

    2 1 1 1
    Investigated diseases:
    • Head and neck cancer metastatic
    Investigated drugs:
    • Eftilagimod Alfa
    • Pembrolizumab
    Belgium Denmark Germany Romania Spain
  • Study Comparing Epcoritamab and Lenalidomide with a Drug Combination for Adults with Relapsed or Refractory Diffuse Large B-Cell Lymphoma

    Not recruiting

    3 1 1 1
    Investigated drugs:
    • Epcoritamab
    • Gemcitabine
    • Lenalidomide
    Belgium Bulgaria Croatia Czechia France Greece +5
  • Study on the Effectiveness and Safety of Tanimilast for Patients with Chronic Obstructive Pulmonary Disease (COPD) and Chronic Bronchitis

    Not recruiting

    3 1
    Investigated drugs:
    • Tanimilast
    Austria Bulgaria Czechia Germany Greece Hungary +6
  • Study on the Effectiveness and Safety of CHF6001 DPI with Roflumilast for Patients with Chronic Obstructive Pulmonary Disease (COPD) and Chronic Bronchitis

    Not recruiting

    3 1
    Investigated drugs:
    • Roflumilast
    • Tanimilast
    Austria Bulgaria Croatia Czechia Estonia Germany +8
  • Study of amlitelimab injection compared to placebo for adults with severe alopecia areata (hair loss)

    Not recruiting

    2 1
    Investigated drugs:
    • Amlitelimab
    Bulgaria Czechia France Germany Italy The Netherlands +2
  • Study of Rocatinlimab compared to Placebo to help adults with Moderate to Severe Asthma

    Not recruiting

    2 1
    Investigated diseases:
    • Asthma
    Investigated drugs:
    • Rocatinlimab
    Bulgaria Czechia Hungary Poland Romania
Previous Page
1 … 39 40 41 42 43 … 67
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Pembrolizumab Carboplatin Cisplatin Paclitaxel Nivolumab Pemetrexed Fluorouracil Capecitabine Oxaliplatin Paclitaxel Albumin-Bound Docetaxel Rituximab Dexamethasone Gemcitabine Prednisolone Etoposide Pemetrexed Disodium Durvalumab Ipilimumab Sodium Chloride Paracetamol Prednisone Letrozole Anastrozole Cemiplimab Lenalidomide Cytarabine Olaparib Atezolizumab Calcium Folinate Show more

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

Acromegaly Acute coronary syndrome Acute lymphocytic leukaemia Acute lymphocytic leukaemia recurrent Acute myeloid leukaemia Acute myocardial infarction Acute promyelocytic leukaemia Acute respiratory failure Adenocarcinoma Adenocarcinoma gastric Adenocarcinoma pancreas Alopecia areata Anaemia Anaplastic lymphoma kinase gene mutation Anti-neutrophil cytoplasmic antibody positive vasculitis Arteriosclerosis Arteriovenous graft thrombosis Asthma Atrial fibrillation Autism spectrum disorder Axial spondyloarthritis B-cell lymphoma B-cell small lymphocytic lymphoma Bladder cancer Bladder cancer stage 0 with cancer in situ Bladder cancer stage I with cancer in situ Bladder transitional cell carcinoma stage IV Breast cancer Breast cancer female Breast cancer metastatic Bronchiectasis Carcinoid syndrome Cardiac failure Cardiac failure chronic Cardiomyopathy Cardiovascular disorder Cerebrovascular accident prophylaxis Cervix carcinoma Cervix carcinoma recurrent Cholangiocarcinoma Chronic hepatitis B Chronic kidney disease Chronic lymphocytic leukaemia Chronic myeloid leukaemia Chronic myelomonocytic leukaemia Chronic obstructive pulmonary disease Chronic rhinosinusitis with nasal polyps Clear cell papillary renal cell carcinoma Clear cell renal cell carcinoma Clostridium difficile infection Coeliac disease Cold urticaria Colitis ulcerative Colorectal adenocarcinoma Colorectal cancer Colorectal cancer metastatic Colorectal cancer stage IV Conjunctivitis allergic COVID-19 Craniocerebral injury Crohn's disease Dermatitis atopic Dermatomyositis Diabetic foot infection Diffuse large B-cell lymphoma Dry age-related macular degeneration Dry eye EGFR gene mutation Embolism Endometrial adenocarcinoma Endometrial cancer Epstein-Barr virus associated lymphoma Erosive oesophagitis Essential thrombocythaemia Factor VIII deficiency Fallopian tube cancer Focal segmental glomerulosclerosis Follicle centre lymphoma follicular grade I, II - III Follicular lymphoma Gastric cancer Gastric cancer recurrent Gastroenteropancreatic neuroendocrine tumour disease Gastrointestinal cancer metastatic Gastrooesophageal reflux disease Glioma Haemolytic uraemic syndrome Haemophilia A with anti factor VIII Head and neck cancer metastatic Hepatic cirrhosis Hepatitis B Hepatobiliary cancer Hepatocellular carcinoma HER2 mutant non-small cell lung cancer HER2 positive breast cancer HER2 positive gastric cancer Hereditary angioedema Hereditary angioedema with C1 esterase inhibitor deficiency Hereditary haemochromatosis Hidradenitis High-grade B-cell lymphoma HIV infection Hormone receptor positive breast cancer Hormone receptor positive HER2 negative breast cancer Hormone-dependent prostate cancer Hormone-refractory prostate cancer Human epidermal growth factor receptor negative Hypereosinophilic syndrome Hyperkalaemia Hypertension Hypertriglyceridaemia Idiopathic pulmonary fibrosis Iron deficiency Ischaemic stroke Juvenile idiopathic arthritis K-ras gene mutation Lung adenocarcinoma Lung neoplasm malignant Lupus nephritis Major depression Malignant lymphoid neoplasm Malignant melanoma Malignant melanoma stage II Malignant melanoma stage III Malignant melanoma stage IV Malignant peritoneal neoplasm Mantle cell lymphoma Marginal zone lymphoma Medullary thyroid cancer Metabolic dysfunction-associated liver disease Metabolic dysfunction-associated steatohepatitis Metastatic gastric cancer Metastatic malignant melanoma Metastatic renal cell carcinoma Microsatellite instability cancer Migraine Migraine with aura Migraine without aura Multiple sclerosis Myasthenia gravis Myelodysplastic syndrome Myelofibrosis Neoplasm Neoplasm malignant Nephrogenic anaemia Neurodermatitis Non-alcoholic steatohepatitis Non-Hodgkin's lymphoma Non-Hodgkin's lymphoma unspecified histology aggressive recurrent Non-small cell lung cancer Non-small cell lung cancer metastatic Non-small cell lung cancer recurrent Non-small cell lung cancer stage I Non-small cell lung cancer stage II Non-small cell lung cancer stage III Non-small cell lung cancer stage IIIA Non-small cell lung cancer stage IIIB Non-small cell lung cancer stage IV Obesity Oesophageal adenocarcinoma Oesophageal cancer metastatic Oesophageal carcinoma Oesophageal squamous cell carcinoma Osteoarthritis Ovarian cancer Ovarian cancer recurrent Ovarian cancer stage III Ovarian cancer stage IV Ovarian epithelial cancer Ovarian epithelial cancer recurrent Pancreatic carcinoma metastatic Paroxysmal nocturnal haemoglobinuria Pemphigoid Philadelphia positive acute lymphocytic leukaemia Pituitary-dependent Cushing's syndrome Plasma cell myeloma Plasma cell myeloma refractory Pneumonia Portal hypertension Primary biliary cholangitis Primary myelofibrosis Progressive multiple sclerosis Progressive relapsing multiple sclerosis Prostate cancer Prostate cancer metastatic Psoriasis Psoriatic arthropathy Pulmonary arterial hypertension Pulmonary hypertension Relapsing multiple sclerosis Relapsing-remitting multiple sclerosis Renal cancer metastatic Renal cancer stage IV Renal cell carcinoma Retinopathy of prematurity Schizophrenia Secondary immunodeficiency Secondary progressive multiple sclerosis Sjogren's syndrome Skin neoplasm excision Skin squamous cell carcinoma metastatic Skin squamous cell carcinoma recurrent Small cell lung cancer Small cell lung cancer extensive stage Small cell lung cancer limited stage Small cell lung cancer metastatic Small cell lung cancer recurrent Squamous cell carcinoma Squamous cell carcinoma of head and neck Squamous cell carcinoma of lung Still's disease Systemic candida Systemic lupus erythematosus Systemic scleroderma Thrombocytopenia Thrombocytosis Thrombosis prophylaxis Thyroid cancer Transitional cell cancer of the renal pelvis and ureter Transitional cell carcinoma Transitional cell carcinoma metastatic Triple negative breast cancer Type 2 diabetes mellitus Urticaria cholinergic Urticaria chronic

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.

Numer nieprawidłowy!
Numer nieprawidłowy!